MRFF Post-Acute Sequelae of COVID-19 Research Plan

This plan supports research investments under the Medical Research Future Fund (MRFF) to improve outcomes for people experiencing Post-Acute Sequelae of COVID-19 (PASC). PASC is also known as long COVID.


MRFF Post-Acute Sequelae of COVID-19 Research Plan

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Strategy or framework
General public

The MRFF PASC Research Plan Expert Advisory Panel developed this plan to guide investments under the MRFF’s Emerging Priorities and Consumer-Driven Research initiative. It includes aims and priority areas for research investment over 4 years from 2024.

Find out from EAP members about the urgent need for a sustainable plan in Improving health outcomes for people living with post-acute sequelae of COVID-19 (long COVID)

Help us improve

If you would like a response please use the enquiries form instead.